N-bromoacetyl-D-leucylglycine: An affinity label for neutral endopeptidase 24.11
- Robert C. Bateman,
- Young Ae Kim,
- ,
- Louis B. Hersh(corresponding author)
- University of Texas Southwestern Medical Center,
- University of Southern Mississippi,
- Howard Hughes Medical Institute
Abstract
Neutral endopeptidase 24.11 is rapidly inactivated by N-bromoacetyl-D-leucylglycine in a reaction which follows first-order kinetics at pH 8 and 37°C. The concentration dependence of inactivation revealed saturation kinetics with an apparent Ki of 10 mM and kinact of 0.4 min-1 at saturating inhibitor concentration. Enzyme can be protected from inactivation by either the substrate Leu5-enkephalin or the competitive inhibitors Phe-Gly or Phe-Ala. Inactivation of enzyme by N-bromo-[14C]acetyl-D-leucylglycine proceeds with the incorporation of a stoichiometric amount of labeled inhibitor. Tryptic digestion of the radioactively labeled enzyme followed by high performance liquid chromatography allowed the isolation of a modified peptide with the sequence T-D-V-H-S-P-G-N-F-R in which histidine (His704) is the modified residue. Site-directed mutagenesis was used to generate a mutant form of the enzyme in which histidine 704 was converted to a glutamine residue. This mutant enzyme retained less than 0.1% of the activity of the native enzyme. These results demonstrate that His704 is at the active site of neutral endopeptidase 24.11 and suggest a catalytic role for this residue.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 8365-8368 (4 pages)Journal (Volume, Issue Number)
Journal of Biological Chemistry (Volume 265, Issue 15)Publication milestones
- Published - 05/25/1990
Publication status
ISSN
0021-9258Publication IDs
- Scopus: 0025286035
- PubMed: 2341387
